 FibroGen, Inc. NASDAQ:FGEN Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Michael Tung - IR Executive Enrique Conterno - CEO Director Juan Graham - CFO Mark Eisner - EVP Chief Medical Officer Thane Wettig - EVP Chief Commercial Officer Christine Chung - SVP, China Operations Conference Call Participants Jason Gerberry - Bank of America Merrill Lynch Jack Padovano - Stifel, Nicolaus Company Michael Yee - Jefferies Alexander Nackenoff - Raymond James Associates Andy Hsieh - William Blair Company Yaron Werber - Cowen Paul Choi - Goldman Sachs Operator Good day, and thank you for standing by. Welcome to FibroGens Third Quarter 2022 Earnings Call. 